• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Frequency of abrupt vessel closure and side branch occlusion after percutaneous coronary intervention in a 6.5-year period (1994 to 2000) at a single medical center.

作者信息

Almeda Francis Q, Nathan Sandeep, Calvin James E, Parrillo Joseph E, Klein Lloyd W

机构信息

Rush University Medical Center, Rush Heart Institute, and Rush Medical College, Chicago, Illinois, USA.

出版信息

Am J Cardiol. 2002 May 15;89(10):1151-5. doi: 10.1016/s0002-9149(02)02295-6.

DOI:10.1016/s0002-9149(02)02295-6
PMID:12008166
Abstract

The aims of this study were to analyze the contemporary trends in the changing incidence of abrupt vessel closure (AVC) after percutaneous coronary intervention (PCI), to determine the impact of intracoronary stenting and glycoprotein IIb/IIIa inhibitors (GPIs) on complication rates and etiologies, and to determine the incidence of side branch occlusion (SBO) as the etiology of AVC in the stent era, complications occurring during 3,300 consecutive PCIs performed from April 1994 to December 2000 at a single referral institution. In this consecutive patient cohort of PCI cases collected over a 6.5-year period, AVC occurred in 103 of 3,300 cases (3.12%). Linear regression analysis over this time frame documented a steadily decreasing incidence of AVC from 5.9% in 1994 to 1.1% in 2000 (-0.76%/per year, 95% confidence interval -0.99 to 0.52, p <0.05). Analysis using Pearson's correlation showed that the decreasing incidence of AVC was inversely correlated with the increasing percentage of intracoronary stents placed over this time period (r = -0.94, p <0.001). Additionally, GPI use increased from 0% in 1995 to 36.0% in 2000 (p = 0.009). The absolute incidence of SBO of a major branch vessel remained relatively stable over this 6.5-year period. However, SBO appeared to be increasing as the etiology of AVC, and accounted for 9.0% of AVC in 1995 compared with 28.0% of AVC in 2000. This increasing trend of the percentage of SBO as the etiology of AVC appeared to correlate with the increased use of stents (r = 0.85, p = 0.015). Thus, the incidence of AVC steadily decreased over the 6.5-year time period, and was associated with the increased use of stents and GPIs; conversely, SBO accounted for an increasing percentage of AVC over this time period.

摘要

相似文献

1
Frequency of abrupt vessel closure and side branch occlusion after percutaneous coronary intervention in a 6.5-year period (1994 to 2000) at a single medical center.
Am J Cardiol. 2002 May 15;89(10):1151-5. doi: 10.1016/s0002-9149(02)02295-6.
2
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).急性心肌梗死患者接受经皮冠状动脉介入治疗时的支架置入与糖蛋白IIb/IIIa抑制:全球急性冠状动脉事件注册研究(GRACE)的结果
Catheter Cardiovasc Interv. 2003 Nov;60(3):360-7. doi: 10.1002/ccd.10653.
3
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).在支架置入术中血小板IIb/IIIa抑制评估试验(EPISTENT)中,阿昔单抗对经皮冠状动脉支架置入术中血管造影并发症的影响。
Am J Cardiol. 2002 Nov 1;90(9):916-21. doi: 10.1016/s0002-9149(02)02653-x.
4
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.药物洗脱支架和糖蛋白 IIb/IIIa 抑制剂在低解剖风险血管中的应用:巴塞尔支架成本效益试验中先前发表数据的回顾性分析。
Clin Ther. 2009 Dec;31(12):2886-93. doi: 10.1016/j.clinthera.2009.12.018.
5
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).非ST段抬高型急性冠脉综合征合并多支冠状动脉疾病患者的特征、治疗及预后:来自PURSUIT研究(不稳定型心绞痛中的血小板糖蛋白IIb/IIIa:使用依替巴肽治疗抑制受体)的观察结果
Cardiology. 2002;98(4):195-201. doi: 10.1159/000067321.
6
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.冠状动脉支架置入术及辅助性血小板糖蛋白IIb/IIIa抑制在复杂动脉粥样硬化病变中的显著益处。
Circulation. 2000 Jul 4;102(1):28-34. doi: 10.1161/01.cir.102.1.28.
7
Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.糖蛋白IIb/IIIa疗法用于治疗1332例接受经皮腔内冠状动脉成形术患者的威胁性或急性血管闭塞的频率及疗效
Am Heart J. 1999 Feb;137(2):234-40. doi: 10.1053/hj.1999.v137.93038.
8
In-hospital clinical outcome in elderly patients with acute myocardial infarction treated with primary angioplasty.接受直接血管成形术治疗的老年急性心肌梗死患者的院内临床结局
Ital Heart J. 2003 Mar;4(3):193-8.
9
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.冠状动脉支架置入术与血小板糖蛋白IIb/IIIa受体阻滞剂的互补临床益处。支架置入术中血小板IIb/IIIa抑制作用评估研究组。
N Engl J Med. 1999 Jul 29;341(5):319-27. doi: 10.1056/NEJM199907293410503.
10
Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry.
Can J Cardiol. 2005 Jan;21(1):27-32.

引用本文的文献

1
Current Challenges in Coronary Bifurcation Interventions.冠状动脉分叉病变介入治疗的当前挑战。
Medicina (Kaunas). 2024 Sep 3;60(9):1439. doi: 10.3390/medicina60091439.
2
Sinus Node Dysfunction due to Occlusion of the Sinus Node Artery during Percutaneous Coronary Intervention.经皮冠状动脉介入治疗中窦房结动脉闭塞导致窦房结功能障碍。
J Interv Cardiol. 2021 Mar 30;2021:8810484. doi: 10.1155/2021/8810484. eCollection 2021.